NY-WEA-GRP-POLICIES
The Women’s Entrepreneurship Accelerator (WEA) today announced the publication of an Advocacy Brief titled “Procurement’s strategic value: Why gender-responsive procurement makes business sense” which presents compelling evidence of the benefits for strengthening the participation of women in private sector supply chains in realizing inclusive economic growth and sustainable development.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220505005120/en/
Developed by UN Women and funded by Mary Kay Inc. in support of WEA, the Advocacy Brief highlights the rollback on progress in achieving gender equality as a result of the COVID-19 pandemic, as well as how increasing levels of economic insecurity, supply chain interruptions and unprecedented climate and environmental shocks have a disproportionate impact on women given their unequal position in society.
The publication echoes previous studies that show that economies have better opportunities to grow and are more resilient to crises if women and men have equal rights.1 However, huge challenges remain. Women entrepreneurs continue to face many obstacles including lack of access to capital on both domestic and international markets; fewer entrepreneurship networks compared with men; and policies that discourage female labor market participation.2 Globally, while one in three businesses are owned by women, 3 women only win an estimated one percent of the global spend of large corporations .4 Unequal gender laws also hinder women’s economic opportunity. For instance, nearly 2.4 billion women of working age still do not enjoy the same economic rights as men.5 Despite these statistics, women entrepreneurs remain a solution for many challenges the world faces today and the evidence shows there is a direct correlation between an increase in women entrepreneurship and economic growth, sustainable development, and more inclusive and resilient societies.6
The data presented in the Advocacy Brief outline how the adoption of gender-responsive (GRP) policies and practices through procurement processes is a strategic lever to mitigate the impact of the structural barriers women face and at the same time improve businesses and strengthen economies. The Advocacy Brief cautions that failing to adopt GRP is a wasted opportunity. The evidence is clear. Reducing gender inequalities is good for business and is smart economics.
“Gender-responsive procurement affects corporate profitability, risk mitigation, innovation, and sustainability. When women entrepreneurs are excluded from the procurement pipeline, companies risk leaving a considerable amount of talent, creativity, and expertise on the table. GRP is a winning business strategy as well as a powerful catalyst for change,” said Deborah Gibbins, Chief Operating Officer, Mary Kay, Inc., and inceptor of WEA.
To inform the Advocacy Brief, UN Women engaged over 350 stakeholders in 2021, of which over 150 private sector companies were represented, and incorporated 7 case studies on companies’ procurement journeys to create an evidence base for why businesses should adopt gender-responsive procurement. Stakeholder engagement took the form of interviews, a survey and a community of practice, which benefitted from dissemination across a wide range of networks, including the membership and networks of UN Global Compact’s (UNGC).
Companies reported that GRP leads to:
- Increased revenue and reduced procurement spend,
- Greater supplier availability and resilience,
- Strengthened brand reputation,
- More innovation and adaptability,
- Improved service delivery due to greater agility, and
- Strengthened markets through local economic development and inclusive growth.
As the Advocacy Brief notes “inclusive and sustainable development is paramount for businesses seeking to both stabilize themselves in a volatile economy and benefit from its future growth. Widening gender inequalities hurt all companies, including women entrepreneurs vital to robust and resilient supply chains and the businesses that rely on them.”
Reflecting the increased focus on environmental, social and governance (ESG) issues by companies, the Advocacy Brief notes how “the implementation of GRP allows companies to practice and institutionalize ESG values and importantly contribute to women’s empowerment and the Sustainable Development Goals (SDGs). Through the adoption of GRP principles, businesses can make progress towards multiple goals, including gender equality (SDG 5) and reduced inequalities (SDG 10) in addition to responsible consumption and production (SDG 12), eliminating poverty (SDG 1) and decent work and economic growth (SDG 8).”
“Achieving the Sustainable Development Goals is not something that can be done by women alone, or by business alone, or by government alone. The only way for us to be able to really make progress is if all – business included – work together towards a common purpose,” said Anita Bhatia , Assistant Secretary-General and Deputy Executive Director of UN Women.
Through the release of this report WEA calls on the private sector to adopt GRP strategies and integrate women into global value chains as a vehicle to advance the SDGs. This makes business sense while at the same time advances women’s economic empowerment which benefits economies and societies at large.
The Advocacy Brief is available here .
About the Women’s Entrepreneurship Accelerator
The Women’s Entrepreneurship Accelerator (WEA) is a multi-stakeholder partnership on women’s entrepreneurship established during UNGA 74. It convenes six UN agencies, International Labour Organization (ILO), International Trade Centre (ITC), International Telecommunication Union (ITU), UN Development Programme (UNDP), UN Global Compact (UNGC), UN Women and Mary Kay Inc. to empower 5 million women entrepreneurs by 2030.
The ultimate goal of the initiative is to maximize the development impact of women entrepreneurship in achieving the Sustainable Development Goals (SDGs) by creating an enabling ecosystem for women entrepreneurs around the world. The Accelerator exemplifies the transformational power of a multi-partnership of unique magnitude to harness the potential of women entrepreneurs. Learn more at we-accelerate. Follow us: Twitter (We_Accelerator), Instagram (@we_accelerator), Facebook (@womensentrepreneurshipaccelerator), LinkedIn (@womensentrepreneurshipaccelerator)
1 World Development Report. 2012: Gender Equality and Development: https://openknowledge.worldbank.org/handle/10986/4391 . |
2 European Commission and OECD Policy Brief on Women’s Entrepreneurship. 2017: https://www.oecd.org/cfe/smes/Policy-Brief-on-Women-s-Entrepreneurship.pdf |
3 World Bank. 2020. Enterprise Surveys, World Bank Gender Data Portal: https://www.worldbank.org/en/data/datatopics/gender |
4 Vazquez, E.A. and A.J. Sherman. 2013. Buying for Impact: How to Buy from Women and Change the World. Charleston, USA: Advantage |
5 World Bank Group. 2022.. Women, Business and the Law 2022. Washington, DC: World Bank |
6 UN Women Facts and Figures: Economic Empowerment: https://www.unwomen.org/en/what-we-do/economic-empowerment/facts-and-figures |
View source version on businesswire.com: https://www.businesswire.com/news/home/20220505005120/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release
‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
